தளம் நெறிமுறைகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தளம் நெறிமுறைகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தளம் நெறிமுறைகள் குழு Today - Breaking & Trending Today

Volunteer's death in Bhopal not related to our vaccine: Bharat Biotech


Volunteer s death in Bhopal not related to our vaccine: Bharat Biotech
PTI
Updated : Jan 10, 2021, 10:06 am IST
The volunteer was reported to be healthy in all the site follow-up calls post seven days of his dosing, the vaccine maker said
  There are several factors that can cause an adverse event during a clinical trial, including the patient s underlying disease, other pre-existing conditions or any other unrelated occurrence like an accident, Bharat Biotech said. (Representational Image: AFP)
Volunteer s death in Bhopal not related to our vaccine: Bharat Biotech
New Delhi: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication. ....

Madhya Pradesh , Andhra Pradesh , New Delhi , Institutional Ethics Committee , People College Of Medical Sciences Research Centre , Madhya Pradesh Police , Haryana Health , Bhopal Police , Central Drugs Control Standards Organization , Site Ethics Committee , Serum Institute , Gandhi Medical College , Bharat Biotech , Drugs Controller General , Medical Sciences , Research Centre , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , Good Clinical Practices , Haryana Health Minister Anil Vij , Bharat Biotech Trial , Bhopal Volunteer Death Reasons , மத்யா பிரதேஷ் , ஆந்திரா பிரதேஷ் , புதியது டெல்ஹி ,

Covaxin row: Bharat Biotech clarifies allegations over volunteer who died after shot


ANI |
Updated: Jan 09, 2021 20:24 IST
New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the site follow up calls post seven days of his dosing.
With regard to reports of a death in Phase III trials, we would like to state that a volunteer passed away on December 21, 2020, and the death was reported to the People s College of Medical Sciences and Research Centre by the son of the deceased, Bharat Biotech stated. ....

Madhya Pradesh , New Delhi , Institutional Ethics Committee , Madhya Pradesh Police , Central Drugs Control Standards Organisation , Research Centre , People College Of Medical Sciences , Bhopal Police , Site Ethics Committee , Gandhi Medical College , Bharat Biotech , Medical Sciences , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , Good Clinical Practices , Covid 19 Vaccine , மத்யா பிரதேஷ் , புதியது டெல்ஹி , நிறுவன நெறிமுறைகள் குழு , மத்யா பிரதேஷ் போலீஸ் , மைய மருந்துகள் கட்டுப்பாடு தரநிலைகள் ஆர்கநைஸேஶந் , ஆராய்ச்சி மையம் , மக்கள் கல்லூரி ஆஃப் மருத்துவ அறிவியல் , போபால் போலீஸ் , தளம் நெறிமுறைகள் குழு ,

Volunteer's Death 'Unrelated' To Covaxin: Bharat Biotech


Volunteer s Death Unrelated To Covaxin: Bharat Biotech
We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded, the vaccine major noted.
PTI
outlookindia.com
2021-01-09T20:56:07+05:30
After the death of a 42-year-old volunteer in Bhopal, who took a dose of Covaxin in the clinical trial of Bharat Biotech s Covaxin, further spurred controversy over the emergency approval of the firm s covid vaccine, Bharat Biotech denied that the vaccine was the cause of the volunteer s death.
Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication. ....

Madhya Pradesh , Andhra Pradesh , Institutional Ethics Committee , People College Of Medical Sciences Research Centre , Madhya Pradesh Police , Haryana Health , Bhopal Police , Central Drugs Control Standards Organization , Site Ethics Committee , Serum Institute , Gandhi Medical College , Bharat Biotech , Volunteer Dies , After Taking Bharat Biotech , Drugs Controller General , Medical Sciences , Research Centre , Covaxin Safe For , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , How Bharat Biotech , Covaxin Got Emergency Approval By Expert , Good Clinical Practices , Haryana Health Minister Anil Vij , Covaxin Death ,

Volunteer's death in Bhopal not related to vaccine, may be of poisoning: Bharat Biotech


Volunteer s death in Bhopal not related to vaccine, may be of poisoning: Bharat Biotech
India
Published: Saturday, January 9, 2021, 20:43 [IST]
New Delhi, Jan 09: Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.
Representational Image
As per the post-mortem report issued by the Gandhi Medical College, Bhopal that the site received from the Bhopal Police, the probable cause of death was due to cardio respiratory failure as a result of suspected poisoning and the case is under police investigation as well, the Hyderabad-based firm said in a statement. ....

Madhya Pradesh , Andhra Pradesh , New Delhi , Institutional Ethics Committee , People College Of Medical Sciences Research Centre , Madhya Pradesh Police , Haryana Health , Bhopal Police , Central Drugs Control Standards Organization , Site Ethics Committee , Serum Institute , Gandhi Medical College , Bharat Biotech , Drugs Controller General , Medical Sciences , Research Centre , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , Good Clinical Practices , Haryana Health Minister Anil Vij , Breaking News , Instant Updates , Volunteers Death In Bhopal , Corona Vaccine , Corona Vaccine Death ,